Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,135 | 663 | 99.5% |
| Education | $74.94 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,955 | 271 | $0 (2024) |
| Novo Nordisk Inc | $1,621 | 119 | $0 (2024) |
| Amgen Inc. | $1,209 | 86 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,199 | 35 | $0 (2024) |
| Boston Scientific Corporation | $376.37 | 3 | $0 (2022) |
| ABBVIE INC. | $342.42 | 11 | $0 (2022) |
| Horizon Therapeutics plc | $267.71 | 15 | $0 (2022) |
| Lilly USA, LLC | $253.78 | 18 | $0 (2023) |
| Abbott Laboratories | $251.32 | 2 | $0 (2021) |
| Amarin Pharma Inc. | $249.39 | 23 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,488 | 36 | Boehringer Ingelheim Pharmaceuticals, Inc. ($668.44) |
| 2023 | $1,659 | 70 | Boehringer Ingelheim Pharmaceuticals, Inc. ($761.33) |
| 2022 | $2,030 | 92 | Boehringer Ingelheim Pharmaceuticals, Inc. ($794.87) |
| 2021 | $2,292 | 101 | Boehringer Ingelheim Pharmaceuticals, Inc. ($970.25) |
| 2020 | $974.76 | 43 | Boehringer Ingelheim Pharmaceuticals, Inc. ($478.71) |
| 2019 | $2,425 | 130 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,130) |
| 2018 | $1,195 | 96 | Boehringer Ingelheim Pharmaceuticals, Inc. ($678.80) |
| 2017 | $4,145 | 103 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,473) |
All Payment Transactions
671 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $123.27 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: DIABETES | ||||||
| 10/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: DIABETES | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: DIABETES | ||||||
| 07/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Bone Health | ||||||
| 07/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: DIABETES | ||||||
| 06/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Respiratory | ||||||
| 05/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 513 | 1,741 | $269,875 | $75,264 |
| 2022 | 14 | 571 | 2,368 | $214,168 | $74,657 |
| 2021 | 20 | 839 | 4,906 | $225,065 | $100,948 |
| 2020 | 17 | 799 | 2,531 | $192,700 | $81,056 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 70 | 408 | $61,200 | $21,115 | 34.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 53 | 226 | $45,200 | $18,073 | 40.0% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 63 | 339 | $67,800 | $12,044 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 100 | $35,000 | $10,843 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 109 | $27,250 | $7,614 | 27.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 182 | $18,200 | $2,263 | 12.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 18 | 21 | $2,100 | $1,520 | 72.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 12 | 13 | $737.87 | $723.10 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 13 | $987.52 | $440.49 | 44.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 36 | $2,160 | $416.98 | 19.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 44 | 102 | $2,040 | $119.43 | 5.9% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 28 | 64 | $1,280 | $51.67 | 4.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 34 | 88 | $3,520 | $38.38 | 1.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 22 | 40 | $2,400 | $4.00 | 0.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 264 | $54,720 | $18,535 | 33.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 63 | 351 | $41,100 | $18,016 | 43.8% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2022 | 55 | 295 | $44,020 | $11,564 | 26.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 50 | 105 | $10,500 | $7,399 | 70.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $6,200 | $4,560 | 73.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 31 | 58 | $11,600 | $4,071 | 35.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 60 | 326 | $18,736 | $3,949 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 30 | $9,000 | $2,967 | 33.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 45 | $8,180 | $2,308 | 28.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 19 | 19 | $3,197 | $912.73 | 28.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 58 | 143 | $1,180 | $181.77 | 15.4% |
About Dr. Luis Luna, MD
Dr. Luis Luna, MD is a Internal Medicine healthcare provider based in Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558453225.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Luna, MD has received a total of $16,210 in payments from pharmaceutical and medical device companies, with $1,488 received in 2024. These payments were reported across 671 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($16,135).
As a Medicare-enrolled provider, Luna has provided services to 2,722 Medicare beneficiaries, totaling 11,546 services with total Medicare billing of $331,926. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Paterson, NJ
- Active Since 09/29/2006
- Last Updated 09/04/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558453225
Products in Payments
- JARDIANCE (Drug) $6,644
- PRADAXA (Drug) $2,002
- Ozempic (Drug) $801.28
- FARXIGA (Drug) $500.04
- Aimovig (Biological) $443.45
- Rybelsus (Drug) $436.01
- AIRSUPRA (Drug) $416.71
- WATCHMAN Access System (Device) $376.37
- EVENITY (Biological) $299.51
- BREZTRI (Drug) $282.61
- Vascepa (Drug) $249.39
- ANORO (Drug) $216.82
- JANUVIA (Drug) $203.24
- Repatha (Biological) $185.34
- Victoza (Drug) $172.13
- TRULICITY (Drug) $169.60
- CRT-Ds (Device) $161.56
- INGREZZA (Drug) $155.24
- Otezla (Drug) $154.73
- DUEXIS (Drug) $152.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Paterson
Dr. Ramon Sandoval, Md, MD
Internal Medicine — Payments: $24,920
Dr. Juan Desueza, M.d, M.D
Internal Medicine — Payments: $15,083
Dr. Henry Sherman, M.d, M.D
Internal Medicine — Payments: $11,678
Dr. Gammal Hassanien, Do, DO
Internal Medicine — Payments: $9,502
Mohamed Dahhan, M.d, M.D
Internal Medicine — Payments: $7,770
Hiren Patel, M.d, M.D
Internal Medicine — Payments: $7,677